Physician
A James Segal MD PA Medeyeassociates
A James Segal MD PA Medeyeassociates was paid $394K by Medicaid between Feb 2018 and Dec 2024, across 31 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 21% of everything it billed.
33Billing provider infoA JAMES SEGAL MD PA MEDEYEASSOCIATES
SOUTH MIAMI, FL 33143
SOUTH MIAMI, FL 33143
33aNPI1710907522assigned 07/21/2006
33bProvider typeOphthalmology Physician
28Total paid$394K
24GClaims20,592
24DCodes billed31
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in Florida
Rank by total paid#22 of 262
Median peer was paid$9K
This provider vs. median45×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 739 | $10K | |
| 2019 | 6,883 | $132K | |
| 2020 | 3,313 | $65K | |
| 2021 | 1,372 | $25K | |
| 2022 | 3,388 | $22K | |
| 2023 | 3,052 | $74K | |
| 2024incomplete | 1,845 | $66K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 21% | 1,900 | 1,177 | $82K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 16% | 1,044 | 821 | $63K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 14% | 1,511 | 987 | $57K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 13% | 1,133 | 794 | $51K |
| 92235 | 8.4% | 1,683 | 1,233 | $33K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.7% | 209 | 201 | $26K |
| 92015 | Determination of refractive state | 6.4% | 342 | 335 | $25K |
| 92134 | 5.0% | 3,516 | 2,474 | $20K | |
| 76512 | 4.5% | 5,142 | 1,822 | $18K | |
| 92250 | 1.1% | 411 | 335 | $4K | |
| V2025 | Deluxe frame | 1.1% | 144 | 140 | $4K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 34 | 28 | $3K |
19 more codes
| J9035 | Injection, bevacizumab, 10 mg | <1% | 194 | $3K |
| V2020 | Frames, purchases | <1% | 59 | $2K |
| 76519 | <1% | 50 | $2K | |
| 92226 | <1% | 889 | $783.22 | |
| 92020 | <1% | 835 | $427.99 | |
| 92083 | <1% | 414 | $271.75 | |
| 92133 | <1% | 383 | $164.78 | |
| 92225 | <1% | 170 | $81.51 | |
| V2799 | Vision item or service, miscellaneous | <1% | 96 | $25.50 |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 0% | 19 | $0.00 |
| J3490 | Unclassified drugs | 0% | 12 | $0.00 |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 0% | 21 | $0.00 |
| 92273 | 0% | 23 | $0.00 | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | 0% | 24 | $0.00 |
| 92201 | 0% | 150 | $0.00 | |
| V2750 | Anti-reflective coating, per lens | 0% | 15 | $0.00 |
| 92202 | 0% | 107 | $0.00 | |
| V2760 | Scratch resistant coating, per lens | 0% | 40 | $0.00 |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCABRERA, BARBIE (ADMINISTRATOR)